Moe SM - Search Results

1

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators; Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. EVOLVE Trial Investigators, et al. Among authors: moe sm. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121374 Free article. Clinical Trial.

2

Beta 2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae.

Moe SM, Sprague SM. Moe SM, et al. Am J Physiol. 1992 Sep;263(3 Pt 2):F540-5. doi: 10.1152/ajprenal.1992.263.3.F540. Am J Physiol. 1992. PMID: 1415583

3

Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol.

Sprague SM, Moe SM. Sprague SM, et al. Among authors: moe sm. Am J Kidney Dis. 1992 Jun;19(6):532-9. doi: 10.1016/s0272-6386(12)80831-6. Am J Kidney Dis. 1992. PMID: 1595701 Clinical Trial.

4

Uremic encephalopathy.

Moe SM, Sprague SM. Moe SM, et al. Clin Nephrol. 1994 Oct;42(4):251-6. Clin Nephrol. 1994. PMID: 7834918 Review.

5

Maintenance of bone mass in patients receiving dialytic therapy.

Moe SM, Yu BO, Sprague SM. Moe SM, et al. Am J Kidney Dis. 1993 Aug;22(2):300-7. doi: 10.1016/s0272-6386(12)70322-0. Am J Kidney Dis. 1993. PMID: 8352257

6

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.

Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ. Lindberg JS, et al. Among authors: moe sm. Kidney Int. 2003 Jan;63(1):248-54. doi: 10.1046/j.1523-1755.2003.00720.x. Kidney Int. 2003. PMID: 12472790 Free article. Clinical Trial.

7

Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.

Moe SM, Drüeke TB. Moe SM, et al. Am J Nephrol. 2003 Nov-Dec;23(6):369-79. doi: 10.1159/000073945. Epub 2003 Oct 9. Am J Nephrol. 2003. PMID: 14551461 Review.

8

Disturbances of bone and mineral metabolism in chronic kidney disease: an international initiative to improve diagnosis and treatment.

Drüeke TB, Moe SM. Drüeke TB, et al. Among authors: moe sm. Nephrol Dial Transplant. 2004 Mar;19(3):534-6. doi: 10.1093/ndt/gfh034. Nephrol Dial Transplant. 2004. PMID: 14767004 Review. No abstract available.

9

A bridge to improving healthcare outcomes and quality of life.

Moe SM, Drüeke TB. Moe SM, et al. Am J Kidney Dis. 2004 Mar;43(3):552-7. doi: 10.1053/j.ajkd.2003.12.002. Am J Kidney Dis. 2004. PMID: 14981614 No abstract available.

10

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG. Block GA, et al. Among authors: moe sm. N Engl J Med. 2004 Apr 8;350(15):1516-25. doi: 10.1056/NEJMoa031633. N Engl J Med. 2004. PMID: 15071126 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters